AbstractPlatelet-activating factor (PAF) is a phospholipid, intermediate in its structure between diacyl- and lysophospholipids. The reorientation of this highly bioactive compound to the inner membrane layer of human erythrocytes after its primary incorporation into the outer membrane layer has been studied. Reorientation was shown to be a slow process with an initial rate of only 0.012 h−1. It does not depend on energy supply. From the steady-state distribution of PAF between inner and outer membrane layers, after very long incubation times (40–50 h), a preference of PAF for the outer membrane layer analogous to that of endogenous lecithin is derived. Our data indicate that the process of simple transbilayer reorientation of PAF is probab...
AbstractThe ability of secretory phospholipase A2 (sPLA2) to hydrolyze cell membranes is highly depe...
The chapter describes the likely molecular mechanisms leading to the aggregation of human red blood ...
1. 1. Rat-blood phospholipids were labeled in vivo with [32P]phosphate. The erythrocytes were treate...
AbstractPlatelet-activating factor (PAF) is a phospholipid, intermediate in its structure between di...
Human polymorphonuclear neutrophils rapidly incorporated radiolabeled platelet-activating factor, 1-...
AbstractWe have investigated the distribution and fatty acid preference of two acyl-CoA transferase ...
AbstractHuman polymorphonuclear leukocytes (PMN) were incubated in the absence or presence of the ca...
AbstractThe human immature K562 erythroid cell line was studied for its capacity to produce and to m...
AbstractTrace amounts of radiolabeled phospholipids were inserted into the outer membrane leaflet of...
AbstractPlatelet-activating factor (PAF) acetylhydrolases are a family of distinct enzymes with the ...
SHEETZ AND SINGER have proposed that the actions of certain amphipathic drugs in producing curvature...
Abstract32P-Labelled washed rabbit platelets were incubated with 0.6 nM platelet activating factor (...
Phosphatidylcholine specific phospholipid exchange protein was used to introduce (14C)-labeled phosp...
phospholipids, human erythrocytes were labeled with radioactive fatty acid (FA). Labeling was perfor...
peer-reviewedIn the late 1960s, Barbaro and Zvaifler described a substance that caused antigen induc...
AbstractThe ability of secretory phospholipase A2 (sPLA2) to hydrolyze cell membranes is highly depe...
The chapter describes the likely molecular mechanisms leading to the aggregation of human red blood ...
1. 1. Rat-blood phospholipids were labeled in vivo with [32P]phosphate. The erythrocytes were treate...
AbstractPlatelet-activating factor (PAF) is a phospholipid, intermediate in its structure between di...
Human polymorphonuclear neutrophils rapidly incorporated radiolabeled platelet-activating factor, 1-...
AbstractWe have investigated the distribution and fatty acid preference of two acyl-CoA transferase ...
AbstractHuman polymorphonuclear leukocytes (PMN) were incubated in the absence or presence of the ca...
AbstractThe human immature K562 erythroid cell line was studied for its capacity to produce and to m...
AbstractTrace amounts of radiolabeled phospholipids were inserted into the outer membrane leaflet of...
AbstractPlatelet-activating factor (PAF) acetylhydrolases are a family of distinct enzymes with the ...
SHEETZ AND SINGER have proposed that the actions of certain amphipathic drugs in producing curvature...
Abstract32P-Labelled washed rabbit platelets were incubated with 0.6 nM platelet activating factor (...
Phosphatidylcholine specific phospholipid exchange protein was used to introduce (14C)-labeled phosp...
phospholipids, human erythrocytes were labeled with radioactive fatty acid (FA). Labeling was perfor...
peer-reviewedIn the late 1960s, Barbaro and Zvaifler described a substance that caused antigen induc...
AbstractThe ability of secretory phospholipase A2 (sPLA2) to hydrolyze cell membranes is highly depe...
The chapter describes the likely molecular mechanisms leading to the aggregation of human red blood ...
1. 1. Rat-blood phospholipids were labeled in vivo with [32P]phosphate. The erythrocytes were treate...